South and Central America Master Patient Index Software Market Growth by 2028

The master patient index software market in South and Central America is expected to grow from US$ 44.9 million in 2021 to US$ 83.1 million by 2028; it is estimated to grow at a CAGR of 9.2% from 2021 to 2028.

Continuous developments in the healthcare sector encourage the healthcare providers to adopt healthcare IT solutions for ensuring easy workflow. MPI software assigns a unique identification number to every patient, and this number allows to maintain consistent and accurate information of every patient, thereby allowing automatic management of patients’ data. MPI software facilitate authorized exchange of patient data among hospitals, rehabilitation centers, pharmacies, and other healthcare providers. The access to exchanged data is enabled through a unique identifying number that is specific to single medical record. Thus, these software avoid the duplication of patients’ information, which may occur due to several factors including demographics, error during data entry, and incomplete proofs. Ensuring accuracy helps healthcare organizations and facility centers in tracking patients previous records when they revisit the facilities.

Health care providers rely on the automated patient management. Thus, health information exchange initiatives, coupled with the heavy dependence on patient management solutions, are driving the demand for MPI software. This software has been a key tool for healthcare centers to maintain clinical, financial, and demographic data across the care continuum, thus playing significant role in providing safe and quality services, which is driving the growth of the master patient index software market.

The COVID‐ 19 pandemic is a critical test for the already overburdened and underfunded public healthcare systems of South and Central America. It suffers from severe inequalities. State-run hospitals and clinics are already overstressed by treating vector‐borne diseases and community‐acquired infections, and high rates of non‐communicable diseases (NCDs). Also, the prevention and treatment of NCDs have been critically affected since the onset of the COVID-19 in the region, as per the Pan American Health Organization (PAHO). Before COVID-19, approximately 81% of all deaths in the region were due to NCDs. An estimated 62 million people live with diabetes, and 1.2 million live with cancer in South and Central America. Moreover, in South and Central America, the Gross Domestic Product (GDP) and central government healthcare expenditure are significantly lower than in developed countries. In 2018, as per the United Nations Economic Commission for Latin America (CEPAL), 16 South American countries invested less than 4% of their GDP in healthcare. The consequences of a lack of investment in public healthcare systems are reflecting during the pandemic. The COVID‐19 pandemic is exacerbating these inequalities by threatening the infrastructure and capacity of state‐owned healthcare systems. Thus, the factors mentioned above are negatively impacting the growth of the market in the region.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the master patient index software market. The South and Central America Master patient index software market is expected to grow at a good CAGR during the forecast period.

South and Central America Master Patient Index Software Market Segmentation         

By Type

• Software
• Service

By Deployment

• Cloud-based
• On Premises

By Country

• South and Central America

  • Brazil
  • Argentina
  • Rest of South and Central America

Companies Mentioned

• McKESSON CORPORATION
• Oracle Corporation
• Wipro Limited
• Allscripts Healthcare Solutions, Inc.
• MEDITECH
• Intersystems Corporation

South and Central America Master Patient Index Software Report Scope